Active, Not Recruiting
Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer
NCT03029403
- Conditions
- Adnexal Diseases, Advanced Cancer, Endocrine Gland Neoplasms, +18 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada